FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 206 filers reported holding FATE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $297,513 | -54.9% | 140,342 | +1.2% | 0.00% | -100.0% |
| Q2 2023 | $660,250 | +99335.2% | 138,708 | +19.0% | 0.00% | 0.0% |
| Q1 2023 | $664 | -42.3% | 116,549 | +2.3% | 0.00% | -50.0% |
| Q4 2022 | $1,150 | -100.0% | 113,941 | +3.3% | 0.00% | -50.0% |
| Q3 2022 | $2,473,000 | -1.6% | 110,353 | +8.9% | 0.00% | 0.0% |
| Q2 2022 | $2,512,000 | -27.5% | 101,378 | +13.4% | 0.00% | 0.0% |
| Q1 2022 | $3,465,000 | -33.2% | 89,382 | +0.9% | 0.00% | -33.3% |
| Q4 2021 | $5,185,000 | -4.6% | 88,624 | -3.3% | 0.01% | -14.3% |
| Q3 2021 | $5,433,000 | -30.1% | 91,673 | +2.4% | 0.01% | -30.0% |
| Q2 2021 | $7,773,000 | +5.3% | 89,564 | +0.0% | 0.01% | 0.0% |
| Q1 2021 | $7,382,000 | -14.8% | 89,527 | -6.0% | 0.01% | -16.7% |
| Q4 2020 | $8,662,000 | +142.4% | 95,265 | +6.6% | 0.01% | +100.0% |
| Q3 2020 | $3,573,000 | +1.2% | 89,394 | -13.1% | 0.01% | 0.0% |
| Q2 2020 | $3,530,000 | +80.7% | 102,888 | +16.9% | 0.01% | +50.0% |
| Q1 2020 | $1,954,000 | +17.9% | 87,980 | +3.9% | 0.00% | +33.3% |
| Q4 2019 | $1,657,000 | +37.2% | 84,690 | +8.8% | 0.00% | +50.0% |
| Q3 2019 | $1,208,000 | -22.8% | 77,815 | +0.9% | 0.00% | -33.3% |
| Q2 2019 | $1,565,000 | +11.1% | 77,094 | -3.9% | 0.00% | 0.0% |
| Q1 2019 | $1,409,000 | +38.4% | 80,220 | +1.1% | 0.00% | +50.0% |
| Q4 2018 | $1,018,000 | +41.8% | 79,379 | +80.1% | 0.00% | +100.0% |
| Q3 2018 | $718,000 | +34.5% | 44,064 | -6.5% | 0.00% | 0.0% |
| Q2 2018 | $534,000 | +23.3% | 47,114 | +6.1% | 0.00% | 0.0% |
| Q1 2018 | $433,000 | +112.3% | 44,386 | +32.7% | 0.00% | – |
| Q4 2017 | $204,000 | +24.4% | 33,440 | -19.5% | 0.00% | – |
| Q3 2017 | $164,000 | +23.3% | 41,527 | +1.4% | 0.00% | – |
| Q2 2017 | $133,000 | – | 40,967 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |